ATE451385T1 - Verbindungen zur inhibierung von apoptose - Google Patents
Verbindungen zur inhibierung von apoptoseInfo
- Publication number
- ATE451385T1 ATE451385T1 AT06820951T AT06820951T ATE451385T1 AT E451385 T1 ATE451385 T1 AT E451385T1 AT 06820951 T AT06820951 T AT 06820951T AT 06820951 T AT06820951 T AT 06820951T AT E451385 T1 ATE451385 T1 AT E451385T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- inhibiting apoptosis
- formula
- well
- apoptosis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940088872 Apoptosis inhibitor Drugs 0.000 abstract 1
- 239000000158 apoptosis inhibitor Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200502890A ES2296484B1 (es) | 2005-11-23 | 2005-11-23 | Composicion farmaceutica para inhibir la apoptosis. |
| PCT/IB2006/003312 WO2007060524A1 (en) | 2005-11-23 | 2006-11-22 | Compounds for the inhibition of apoptosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451385T1 true ATE451385T1 (de) | 2009-12-15 |
Family
ID=37846980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06820951T ATE451385T1 (de) | 2005-11-23 | 2006-11-22 | Verbindungen zur inhibierung von apoptose |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20090298781A1 (de) |
| EP (1) | EP1963357B1 (de) |
| JP (1) | JP2009516733A (de) |
| KR (1) | KR20080091103A (de) |
| CN (1) | CN101370820A (de) |
| AT (1) | ATE451385T1 (de) |
| AU (1) | AU2006318131B2 (de) |
| BR (1) | BRPI0618837A2 (de) |
| CA (1) | CA2630926A1 (de) |
| DE (1) | DE602006011053D1 (de) |
| EA (1) | EA014874B1 (de) |
| EC (1) | ECSP088464A (de) |
| ES (2) | ES2296484B1 (de) |
| IL (1) | IL191670A0 (de) |
| NZ (1) | NZ568472A (de) |
| WO (1) | WO2007060524A1 (de) |
| ZA (1) | ZA200804499B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2293834B1 (es) * | 2006-07-20 | 2009-02-16 | Consejo Superior Investig. Cientificas | Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas. |
| CN102574818B (zh) * | 2009-07-30 | 2015-02-25 | 萨尔瓦特实验室股份有限公司 | Apaf-1抑制剂化合物 |
| ES2611185T3 (es) | 2013-05-20 | 2017-05-05 | Fundación Comunidad Valenciana Centro De Investigación Principe Felipe | Conjugados polímero-fármaco para el tratamiento de la amiloidosis |
| US10561736B1 (en) | 2019-01-09 | 2020-02-18 | Spiral Therapeutics, Inc. | Apoptosis inhibitor formulations for prevention of hearing loss |
| WO2023225277A1 (en) * | 2022-05-19 | 2023-11-23 | Ohio State Innovation Foundation | Peptidyl flavor modifiers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4499917B2 (ja) * | 1998-03-09 | 2010-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | インターロイキン−１β変換酵素のインヒビターとしての１，２−ジアゼパン誘導体 |
| ES2169690B1 (es) * | 2000-10-06 | 2004-03-16 | Diverdrugs Sl | Trimeros de n-alquilglicina capaces de proteger a neuronas contra agresiones excitotoxicas, y composiciones que los contienen. |
-
2005
- 2005-11-23 ES ES200502890A patent/ES2296484B1/es not_active Expired - Fee Related
-
2006
- 2006-11-22 DE DE602006011053T patent/DE602006011053D1/de active Active
- 2006-11-22 EP EP06820951A patent/EP1963357B1/de not_active Not-in-force
- 2006-11-22 CN CNA2006800516396A patent/CN101370820A/zh active Pending
- 2006-11-22 ZA ZA200804499A patent/ZA200804499B/xx unknown
- 2006-11-22 US US12/094,828 patent/US20090298781A1/en not_active Abandoned
- 2006-11-22 CA CA002630926A patent/CA2630926A1/en not_active Abandoned
- 2006-11-22 ES ES06820951T patent/ES2338164T3/es active Active
- 2006-11-22 AT AT06820951T patent/ATE451385T1/de not_active IP Right Cessation
- 2006-11-22 AU AU2006318131A patent/AU2006318131B2/en not_active Ceased
- 2006-11-22 BR BRPI0618837-0A patent/BRPI0618837A2/pt not_active IP Right Cessation
- 2006-11-22 EA EA200801137A patent/EA014874B1/ru not_active IP Right Cessation
- 2006-11-22 JP JP2008541842A patent/JP2009516733A/ja not_active Withdrawn
- 2006-11-22 WO PCT/IB2006/003312 patent/WO2007060524A1/en not_active Ceased
- 2006-11-22 NZ NZ568472A patent/NZ568472A/en unknown
- 2006-11-22 KR KR1020087015209A patent/KR20080091103A/ko not_active Ceased
-
2008
- 2008-05-22 IL IL191670A patent/IL191670A0/en unknown
- 2008-05-22 EC EC2008008464A patent/ECSP088464A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA014874B1 (ru) | 2011-02-28 |
| EP1963357B1 (de) | 2009-12-09 |
| ES2296484A1 (es) | 2008-04-16 |
| ECSP088464A (es) | 2008-08-29 |
| AU2006318131A1 (en) | 2007-05-31 |
| AU2006318131B2 (en) | 2011-07-21 |
| NZ568472A (en) | 2011-05-27 |
| IL191670A0 (en) | 2008-12-29 |
| CN101370820A (zh) | 2009-02-18 |
| JP2009516733A (ja) | 2009-04-23 |
| ES2296484B1 (es) | 2009-04-01 |
| EA200801137A1 (ru) | 2008-12-30 |
| WO2007060524A1 (en) | 2007-05-31 |
| ZA200804499B (en) | 2009-10-28 |
| US20090298781A1 (en) | 2009-12-03 |
| ES2338164T3 (es) | 2010-05-04 |
| DE602006011053D1 (de) | 2010-01-21 |
| EP1963357A1 (de) | 2008-09-03 |
| CA2630926A1 (en) | 2007-05-31 |
| BRPI0618837A2 (pt) | 2011-09-13 |
| KR20080091103A (ko) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE473975T1 (de) | Chemische verbindungen | |
| ATE398613T1 (de) | Chemische verbindungen | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| EA201170772A1 (ru) | Органические соединения | |
| EA200901138A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| GEP20146060B (en) | Pyridyl inhibitors of hedgehog signalling | |
| SE0301700D0 (sv) | Novel compounds | |
| CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
| MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
| MY148534A (en) | Inhibitors of human immunodeficiency virus replication | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| EA200801997A1 (ru) | Новые соединения | |
| MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| EA200700601A1 (ru) | Производные фениламинопиримидина как ингибиторы bcr-abl | |
| TW200738627A (en) | Trialkylsilyl-indoles | |
| TW200738659A (en) | Novel compounds | |
| TW200745122A (en) | New compounds I | |
| IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
| SE0403086D0 (sv) | Compounds | |
| EA200870223A1 (ru) | Производные бензоизоиндола для лечения боли | |
| EA200701178A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |